May 15, 2026

Registration open for Nebraska Drug Discovery Symposium

A woman in portrait on the left and a gray-haired man in portrait on the right.

Dame Carol Robinson of Oxford University and Stephen Fesik of Vanderbilt University will speak at the upcoming ND3P Symposium.

Registration for the sixth annual Nebraska Drug Discovery and Development Pipeline ND3P Symposium is now open.

The fully virtual symposium will be 9 a.m. to 4 p.m. June 9 and 10.

The ND3P Symposium brings together leading faculty, postdoctoral fellows, graduate students, university leaders and industrial representatives from around the state, with a particular focus on building new ties between the flagship NU campus in Lincoln, and the UNMC medical campus in Omaha. The goal is to discuss new tools, technologies, modalities and directions in fundamental and biomedically relevant science, and to build new collaborations along the way.

The program keeps with the symposium’s tradition of bringing in world leaders as plenary lecturers to kick off each day of a thought-provoking symposium related to drug discovery.

Plenary speakers include Dame Carol Robinson of Oxford University and Stephen Fesik of Vanderbilt University. Robinson is the director of the Kavli Institute for Nanoscience Discovery. Robinson will present on “Membrane Proteins in the Gas Phase.” Fesik is the Orrin H. Ingram II Chair in Cancer Research and will present on “SAR by NMR.”

The symposium is fully virtual and open for anyone to attend. Register online.